Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5189765

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCCC[C@H]1CN(c2cccc(OC(F)(F)F)c2)C(=O)CN1Cc1cncn1Cc1ccc(C#N)c(F)c1

Basic Information

ChEMBL ID CHEMBL5189765
Phase Preclinical
Structure Type MOL
InChI Key WRNSPFWIUHUJNC-QFIPXVFZSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

529.5
MW (Da)
5.25
ALogP
6
HBA
0
HBD
74.4
PSA (Ų)
0.35
QED
2
Ro5 Violations
9
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C27H27F4N5O2
MW 529.54
Aromatic Rings 3
Heavy Atoms 38
NP-Likeness -1.55

Activity Summary

IC50 1 meas. best 7.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 7.4 7.4 40.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 40.0 nM 7.4 Inhibition of Cryptococcus neoformans farnesyltransferase assessed as inhibition... 36218371

Literature References

PubMed DOI Target Context # Activities
36218371 10.1021/acs.jmedchem.2c00902 Unchecked 3
36218371 10.1021/acs.jmedchem.2c00902 Cryptococcus neoformans 1

Data from ChEMBL 36 via Core Engine